Perry Drug Recalls HCG Vials Due to Sterility Assurance Concerns
Perry Drug Inc. is recalling HCG Low Dose vials in Kansas and Missouri due to quality control issues affecting sterility assurance.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of sterility assurance in sterile compounded products, which poses a significant risk of serious injury or infection.
Plain-English summary
Perry Drug Inc. is recalling HCG Low Dose 10 IU / 0.1 mL, 5 mL vials (NDC 88888-2596-17) compounded by Perry Drug Compounding Pharmacy in Overland Park, Kansas. The recall covers all lots of sterile products compounded by the pharmacy that are within their expiration date.
The recall was initiated due to concerns associated with quality control procedures that present a potential risk to sterility assurance. These concerns were observed during a recent FDA inspection. The affected products were distributed in Kansas and Missouri.
Consumers who have these products should stop using them and contact their healthcare provider or the recalling firm for further instructions. The specific lot codes identified in the recall are 141010I (dated 11/10/14) and 141017F (dated 11/17/14).
The recalled product
- Product
- HCG Low Dose 10 IU / 0.1 mL, 5 Ml vials, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS ---NDC 88888-2596-17
- Manufacturer
- Perry Drug Inc.
- Affected units
- 2
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- 141010I
- 11/10/14
- 141017F
- 11/17/14
Distribution
Part of a larger recall action
This product is one of 17 recalled by Perry Drug Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 17 products in this recall →Related recalls
Same manufacturer · Perry Drug Inc.
See all →- SeverePerry Drug Recalls Cyclosporine Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2014-12-03
- SeverePerry Drug Recalls Tri-mix Antidote Syringes Due to Sterility Concerns
FDA (Drugs) · 2014-12-03
- SeverePerry Drug Recalls HCG Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-12-03
- SeverePerry Drug Recalls Methyl B12 Syringes Due to Sterility Concerns
FDA (Drugs) · 2014-12-03
- SeverePerry Drug Recalls Phenylephrine Syringes Due to Sterility Concerns
FDA (Drugs) · 2014-12-03
Same hazard · sterility assurance
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- SevereChloraPrep One-Step Applicators Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2026-07-08
- SevereArrow access trays and PSI kits contain recalled supplier drugs
FDA (Devices) · 2026-06-24
Similar recalls
- SevereFDA Recalls HCG Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2015-09-23
- SevereHCG Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereHCG Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23
- SevereHCG Injection Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2015-09-23
- SevereUS Compounding Recalls HCG/B12 Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-25
- SevereFDA Recalls 1-HCG 1000 IU/ML Due to Sterility Concerns
FDA (Drugs) · 2016-06-15